SNS-103
sensei biotherapeutics
['sensei']
sensei biotherapeutics presents new preclinical data on sns-103 targeting entpdase1 (cd39) at the american association for cancer research (aacr) annual meeting 2023 
Pharmaceutical News - Direct Information